Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.

Prisons play a significant role in the epidemiology of drug-resistant tuberculosis. A total of 114 Mycobacterium tuberculosis isolates recovered from patients in the Archangel prison (Archangel, Russia) in 2001 were studied using restriction fragment-length polymorphism analysis and spoligotyping. Drug susceptibility was analyzed by the radiometric broth method (BACTEC; Becton Dickinson Diagnostic Systems). According to genotyping studies, 87 (76.3%) of the isolates belonged to the W-Beijing family. Nearly all (96.6%) W-Beijing isolates were part of a cluster, whereas only 25.9% of the other isolates were clustered (P<.001). The largest cluster comprised 43 patients. Multidrug resistance was high among new (34.0%) and previously treated (55.0%) cases. Resistance to ethambutol (OR, 3.4; 95% CI, 1.0-12.7; P=.03) and streptomycin (OR, 4.2; 95% CI, 1.5-11.6; P=.001) was significantly associated with infection with W-Beijing isolates. Tuberculosis due to drug-resistant W-Beijing isolates is a major problem in the Archangel prison.

[1]  V. Stern,et al.  Problems in Prisons Worldwide, with a Particular Focus on Russia , 2001, Annals of the New York Academy of Sciences.

[2]  P. de Rijk,et al.  Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin , 1997, Antimicrobial agents and chemotherapy.

[3]  M. Pfaller.  Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria. , 1994, American journal of clinical pathology.

[4]  Dick van Soolingen,et al.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. , 2002 .

[5]  G Middlebrook,et al.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. , 1977, The American review of respiratory disease.

[6]  J T Douglas,et al.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia , 1995, Journal of clinical microbiology.

[7]  M. Hazbón,et al.  Clinical and programmatic mismanagement rather than community outbreak as the cause of chronic, drug-resistant tuberculosis in Buenaventura, Colombia, 1998. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  S. Svenson,et al.  Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia , 2001, Journal of Clinical Microbiology.

[9]  L. Rigouts,et al.  Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. , 2001, Emerging infectious diseases.

[10]  D. Glenn,et al.  Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens , 1983, Journal of clinical microbiology.

[11]  J. Musser,et al.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  Barun Mathema,et al.  Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. , 2002, Trends in microbiology.

[13]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[14]  P. Palittapongarnpim,et al.  Restriction fragment length polymorphism study of Mycobacterium tuberculosis in Thailand using IS6110 as probe. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[16]  D. van Soolingen,et al.  Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. , 2000, Emerging infectious diseases.

[17]  M. Kimerling.  The Russian equation: an evolving paradigm in tuberculosis control. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  Lung Disease,et al.  Tuberculosis guide for low income countries , 1996 .

[19]  N. Dunlap.  The use of RFLP as a tool for tuberculosis control: utility or futility? , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  D. Caugant,et al.  Spread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia , 2002, Journal of Clinical Microbiology.

[21]  D. van Soolingen,et al.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements , 2001, Journal of internal medicine.

[22]  V. Baumanis,et al.  Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia , 2002, Journal of Clinical Microbiology.

[23]  H. Soini,et al.  Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. , 1998, Scandinavian journal of infectious diseases.

[24]  M. Aziz,et al.  Guidelines for surveillance of drug resistance in tuberculosis , 2009 .

[25]  H. Soini,et al.  katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients , 1996, Antimicrobial agents and chemotherapy.

[26]  D. van Soolingen,et al.  Restriction fragment length polymorphism typing of mycobacteria. , 2001, Methods in molecular medicine.

[27]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[28]  E. Vynnycky,et al.  Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. , 1999 .